Pharmaceutical marketers spend a great deal of time watching competitors. They track new campaigns, messaging, channel investments, launches, and market share. However, what happens when every company is watching the same small group of rivals? A smarter approach to competitive benchmarking looks beyond direct competitors and asks a more useful question: Who is genuinely best at the experience or capability we want to improve?
That shift matters because healthcare professionals and patients do not judge pharma experiences only against other pharma brands. Their expectations are shaped by the seamless digital services, personalization, convenience, and support they encounter everywhere else. Therefore, marketers that benchmark only within their therapeutic category may be measuring themselves against a standard that is already behind customer expectations.
Table of Contents
- Why traditional pharma benchmarking can limit innovation
- How cross-industry benchmarking changes the comparison
- What pharma marketers should benchmark
- Turning outside ideas into competitive advantage
- Conclusion
- FAQs
Why Traditional Pharma Competitive Benchmarking Falls Short
Traditional benchmarking has an obvious purpose. Brand teams need to understand how competing therapies are positioned, where rivals spend media dollars, and how competitors engage healthcare professionals. Yet that information should be a starting point rather than the boundary of strategic thinking.
When every company benchmarks the same competitors, an industry can gradually become more alike. Brands use similar channels, develop comparable content, track similar KPIs, and design familiar customer journeys. Consequently, incremental improvement starts replacing meaningful innovation.
The problem becomes more important as customer expectations change. Pharma brands are no longer competing only for market share. Instead, they also compete for attention, trust, convenience, and relevance.
As discussed in Pharma Marketing Network’s examination of the pharma customer experience gap, disconnected touchpoints can make otherwise strong marketing programs feel fragmented. A physician does not care that email, field sales, media, and medical communications are managed by separate teams. The physician simply experiences one brand.
Therefore, pharma benchmarking should measure the experience customers actually receive, not merely how a brand performs against another drug company.
Look Beyond Pharma With Cross-Industry Benchmarking
Cross-industry benchmarking starts by changing the question. Instead of asking, “Which pharma company does this best?” marketers can ask, “Which organization anywhere does this best?”
For example, a pharma team exploring personalization might study leading streaming or e-commerce platforms. A patient services team could examine financial services companies that simplify complicated enrollment processes. Meanwhile, an omnichannel team might study retailers that connect digital and human interactions without forcing customers to start over.
The goal is not to copy another industry’s tactics. Healthcare has unique regulatory, privacy, scientific, and ethical requirements. However, the underlying principles behind a great experience can often travel across industries.
McKinsey has noted that increasingly sophisticated digital audiences expect more tailored engagement, while analytics-enabled omnichannel models can improve how pharmaceutical companies interact with HCPs. Its research on omnichannel commercial models in pharma also highlights the importance of personalization, analytics, and continuous learning.
Therefore, marketers should separate an outside company’s capability from the exact tactic used to deliver it. Amazon’s checkout process cannot simply become a pharma program. Yet its focus on reducing unnecessary friction can inspire teams to reconsider how patients navigate support services.
That distinction turns benchmarking into innovation rather than imitation.
What Should Pharma Marketers Benchmark?
Effective competitive benchmarking begins with capabilities, not company names. First, identify a customer or commercial problem. Then find organizations that solve that particular problem exceptionally well.
Customer experience is one useful area. Teams can examine how leading consumer brands reduce friction, maintain continuity, and make complex processes feel simple. Likewise, service design can reveal ways to improve patient onboarding or HCP support.
Omnichannel engagement offers another opportunity. Pharma has invested heavily in adding digital channels. However, adding channels is different from creating a connected experience. Pharma Marketing Network has previously explored why unified experience design can go beyond conventional omnichannel execution.
Digital marketing teams should also study organizations that excel at content discovery, audience relevance, measurement, and responsible personalization. Healthcare-focused digital partners such as eHealthcare Solutions can help marketers consider how these broader digital principles translate into regulated healthcare environments.
Finally, benchmark operating capabilities. How quickly can leading organizations identify customer signals, make decisions, test improvements, and share insights? Sometimes the most valuable competitive advantage is not a campaign. Instead, it is the system that allows an organization to learn faster than everyone else.
Turn Benchmarking Insights Into Pharma Competitive Advantage
Looking outside pharma only creates value when insights lead to action. Therefore, teams need a repeatable process for converting observations into compliant experiments.
Start by defining the capability you want to improve. Next, identify three types of benchmarks: a direct pharma competitor, a healthcare company outside your category, and a best-in-class organization from another industry. This creates a wider comparison without losing relevant context.
Then examine the gap between your current experience and the best example. Avoid focusing only on visible features. Instead, ask what processes, data, technology, organizational structure, and customer insight make the superior experience possible.
Afterward, translate the principle into a small healthcare-appropriate test. A lesson from hospitality about recognizing returning customers, for instance, might inspire better continuity across HCP interactions. Similarly, a lesson from banking about simplifying complex decisions could influence patient education design.
Measurement also matters. Teams should establish baseline metrics before testing changes and determine whether the new approach reduces friction, improves engagement, increases satisfaction, or strengthens another meaningful outcome.
Most importantly, benchmarking should become continuous. Markets move too quickly for an annual competitive review to capture every emerging capability. A modern benchmarking program should function as an ongoing learning system that regularly scans healthcare and other industries for better ways to solve customer problems.
Conclusion
Pharma brands still need to understand their direct competitors. However, competitors should not define the ceiling for innovation.
The strongest benchmark may come from a retailer that removes friction, a technology company that makes personalization effortless, or a service organization that turns a complicated journey into a simple one. By studying those capabilities, marketers can escape category-wide thinking and discover ideas their direct competitors may not yet see.
Ultimately, competitive advantage rarely comes from becoming slightly better at doing what everyone else already does. It comes from finding a better standard, adapting it responsibly, and building capabilities others will eventually want to benchmark.
FAQs
What is a competitive benchmarking strategy?
It is a structured approach for comparing a company’s capabilities and performance with other organizations to identify gaps, opportunities, and better practices. Strong benchmarking programs include both direct competitors and best-in-class companies outside the industry.
Why should pharma benchmark companies outside healthcare?
Customers form expectations through experiences across many industries. Therefore, studying leaders in retail, technology, financial services, hospitality, and other sectors can reveal new approaches to personalization, convenience, digital engagement, and service design.
Does cross-industry benchmarking mean copying consumer brands?
No. Pharma companies operate under specific regulatory, privacy, and ethical requirements. The goal is to understand the principle behind a successful experience and adapt that principle appropriately for healthcare.
What should pharma marketers benchmark first?
Start with a specific problem rather than a list of companies. Customer journey friction, omnichannel continuity, personalization, digital service, measurement, and speed of learning are useful areas to examine.
How often should competitive benchmarking be conducted?
Benchmarking should be an ongoing process rather than an annual exercise. Regular reviews help teams identify emerging capabilities early and test relevant ideas before they become standard practice across the pharmaceutical industry.
This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.
